These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13887846)

  • 1. [Durabolin in bone pathology].
    DREYFUS P
    Gaz Med Fr; 1961 Nov; 68():2579-81. PubMed ID: 13887846
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
    MALMIO K; HISI-BRUMMER L; HORTLING H
    Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex hormones and mammary cancer; experience with durabolin.
    VAN DER WERFF JT
    Br Med J; 1958 Oct; 2(5101):881-3. PubMed ID: 13572933
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of secondary deposits in bone from carcinoma of the breast with radio-active phosphorus and Durabolin.
    RIORDAN DJ; BROWNE PA
    J Ir Med Assoc; 1961 Aug; 49():40-4. PubMed ID: 13741800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biochemical effects of nandrolone phenilpropionate (durabolin) and nandrolone decanoate (deca-durabolin) in diabetic retinopathies].
    HOUTSMULLER AJ; HENKES HE
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():57-62. PubMed ID: 14449333
    [No Abstract]   [Full Text] [Related]  

  • 6. Nandrolone phenpropionate: a new palliative agent in the management of mammary carcinoma.
    SZUJEWSKI HA
    Am Pract Dig Treat; 1959 Dec; 10():2157-9. PubMed ID: 13836459
    [No Abstract]   [Full Text] [Related]  

  • 7. Paradoxical response of metastatic breast cancer to 17-ethyl-19-nortestosterone.
    EMERSON K; MULLER J; de SOUZA ; LOUTFI G
    Ann Intern Med; 1961 Nov; 55():742-8. PubMed ID: 13890104
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal therapy in cancer of the breast. XIV. The effect of 19-nortestosterone propionate therapy on clinical course and hormonal excretion.
    SEGALOFF A; BOWERS CY; RONGONE EL; MURISON PJ
    Cancer; 1959; 12(4):735-7. PubMed ID: 13663017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe osteoporosis of the spine treated with high doses of Durabolin].
    OLESEN V
    Ugeskr Laeger; 1960 Nov; 122():1655-7. PubMed ID: 13730722
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of the use of Durabolin on diphtheria patients].
    MINAMISAWA Y; SAITO M
    Nihon Densenbyo Gakkai Zasshi; 1962 May; 36():39-42. PubMed ID: 14474273
    [No Abstract]   [Full Text] [Related]  

  • 11. Favourable effect of durabolin (19-nor-androstenolon-phenyl-propionate) on diabetic retinopathy.
    BEAUMONT P; vd BOOGAARD J
    Ophthalmologica; 1960 Jun; 139():480-4. PubMed ID: 13797980
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoporosis treatment with nandrolone phenpropionate.
    BANGHART HE
    Pa Med J; 1961 Aug; 64():984-6. PubMed ID: 13686583
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of 19-nor-androstenolone phenylpropionate (durabolin) to prevent the alterations produced by cortisone on the growing bone in rats.
    LARON Z; BOSS JH
    Endocrinology; 1961 Sep; 69():608-12. PubMed ID: 13759150
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of "Deca-Durabolin" on the residual nitrogen level in blood].
    BERGMANN M
    Med Welt; 1962 Mar; 10():538-43. PubMed ID: 13867773
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of anabolic steroid (durabolin) in the conservative management of acute renal failure.
    GJORUP S; THAYSEN JH
    Acta Med Scand; 1960 Jul; 167():227-38. PubMed ID: 13705879
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
    BARTA ; CSERE M; NABRADY J
    Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of nor-androstenolone phenylpropionate (Durabolin) on weight increase in atrophic children].
    UJSAGHY P
    Gyermekgyogyaszat; 1962 Jul; 13():210-8. PubMed ID: 13923627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on nitrogen balance. Effect of durabolin on nitrogen, potassium and sodium balance in operated patients].
    MANICKI J
    Pol Tyg Lek; 1960 Nov; 15():1796-9. PubMed ID: 13766169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.